Research Group Next-Generation Sequencing

The identification of pathogenic genetic variants is a basic tool to discover the principals of inherited or acquired diseases. Progress in sequencing technologies over the last decade enables to sequence a patients genome or exome within several days. We provide assistance in study design, prepare the sequencing libraries starting from blood or customer isolated DNA/RNA in an automated high throughput manner and perform sequencing as 100 bp PE run on the Illumina HiSeq2000 and HiSeq2500. Beside whole genome or whole exome analysis, we perform whole transcriptome sequencing for expression studies as well as chromatin immunoprecipitation (ChIP) sequencing to identify interactions between DNA and proteins. Data analysis is accomplished using publicly available tools and custom scripts due to our bioinformatic unit. The in-house variant database with more than 5.000 samples enables precise filtering of the identified variant using project specific criteria and provides control genotypes.

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.